| A further look into the PLCO data with open questions on PSA, active surveillance, and risk factors in prostate cancer |
Yulong Gu |
Stockton University |
PLCO |
Dec 5, 2022 |
PLCO-1118 |
| Dataset Analysis for Identifying General Data Statistics |
Jonathan Hubermann |
Concordia University |
PLCO |
Dec 5, 2022 |
PLCO-1119 |
| Data Integration and Imputation Across Multiple Medical Datasets |
Vivatchai Kaveeta |
Chiang Mai University |
PLCO |
Dec 5, 2022 |
PLCO-1120 |
| Data Science Project: To develop prediction model for Lung Cancer Risk |
Ella Buzhor |
Holon Institute of Technology (HIT) |
PLCO |
Dec 5, 2022 |
PLCO-1121 |
| Machine Learning Model to Predict Various Types of Cancer |
Bence Lukacsy |
Barrington High School |
PLCO |
Dec 5, 2022 |
PLCO-1112 |
| AI-based Bladder cancer risk stratification. |
Okyaz Eminaga |
Okyaz Eminaga |
PLCO |
Nov 28, 2022 |
PLCOI-1110 |
| Weakly-supervised learning to develop an AI-based risk-stratification of PLCO cancers |
Okyaz Eminaga |
Okyaz Eminaga |
PLCO |
Nov 28, 2022 |
PLCOI-1111 |
| Investigating polygenic prediction of cancer risk and cancer-related phenotypes |
Gil McVean |
Genomics plc |
PLCO |
Nov 22, 2022 |
PLCO-1106 |
| Associations of healthy lifestyle with life expectancy and cancer free life expectancy |
Eleanor Watts |
National Cancer Institute |
PLCO |
Nov 21, 2022 |
PLCO-1100 |
| Greenspace, noise pollution, and cancer risk in the PLCO cohort |
Rena Jones |
National Cancer Institute |
PLCO |
Nov 21, 2022 |
PLCO-1105 |
| Mathematical modeling of biomarker dynamics in cancer patients |
Frederick Adler |
University of Utah |
PLCO |
Nov 14, 2022 |
PLCO-1099 |
| Risk Factors of Prostate Cancer - A Statistical Analysis |
Francesco Patrucco |
Humanitas University |
PLCO |
Nov 9, 2022 |
PLCO-1098 |
| Machine Learning Model to Predict Colorectal Cancer |
Bence Lukacsy |
Barrington High School |
PLCO |
Nov 9, 2022 |
PLCO-1097 |
| Clarifying Lung Cancer Risk Among Breast Cancer Survivors |
Keith Sigel |
The Mount Sinai Hospital |
PLCO |
Nov 9, 2022 |
PLCO-1092 |
| Reexamine trial outcomes in PLCO to identify interactions of screening effects with screen results and other covariates |
Hormuzd Katki |
NCI |
PLCO |
Nov 1, 2022 |
PLCO-1091 |
| Association between use of non-steroidal anti-inflammatory drugs (NSAIDs) and risk of pancreatic cancer in a national prospective cohort study |
Yunpeng Yu |
Indiana University |
PLCO |
Nov 1, 2022 |
PLCO-1088 |
| ANALYSIS OF THE EFFECT OF CHEMOTHERAPY IN OVARIAN CANCER TREATMENT USING DATA MINING |
Kezban Alpan |
Middlesex University |
PLCO |
Nov 1, 2022 |
PLCO-1089 |
| Assessing the effect of different kinds of explanations on how much people trust a cancer diagnosis |
Ben Armstrong |
Massachusetts Institute of Technology |
PLCO |
Oct 27, 2022 |
PLCO-1080 |
| Alcohol Intake Across the Life Course and Risk of Ovarian Cancer in Postmenopausal Women |
Alexandra Schmidt |
University of North Dakota |
PLCO |
Oct 19, 2022 |
PLCO-1078 |
| Synthetic generation and tagging of CXR and pathology images |
Jonathan Pearson |
NHS Commissioning Board (NHS England) |
PLCO |
Oct 18, 2022 |
PLCOI-1077 |
